Biosecure Act: A Cure for Supply Chain Weakness or More Red Tape?

Biosecure Act: A Cure for Supply Chain Weakness or More Red Tape?

Tuesday, May 20, 2025 11:15 AM to 11:35 AM · 20 min. (America/New_York)
Main Stage Theater
Track - Market Trends in Pharma

Information

The BioSecure Act, and the actions that Chinese companies have taken as a result, is much more than what meets the eye. It is reflective of the successes and failures of the Chinese biotech industry over the past decade, and provides lessons for the entire industry.

Topic
Supply ChainRegulation and PolicyMarket Insights

Log in

See all the content and easy-to-use features by logging in or registering!